跳至主要内容
临床试验/CTRI/2019/03/018095
CTRI/2019/03/018095招募中不适用

ICMR-INDIAB Study -A large cross-sectional epidemiological study with the objectives to determine the national prevalence of type 2 diabetes mellitus & pre-diabetes in India and complications of diabetes in the metros

Indian Council of Medical Research30 个研究点 分布在 1 个国家目标入组 124,000 人开始时间: 2008年10月13日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
124,000
试验地点
30
主要终点
Prevalence of Pre-diabetes,diabetes and associated complications

研究概览

简要总结

This study is an ongoing cross sectional study, which aims to estimate the national prevalence of diabetes and prediabetes in India by estimating the state wise prevalence of the same ( 28 states, 1 NCT of Delhi and 2 Union Territories) . This study will also  determine the prevalence of hypertension, dyslipidemia, and coronary artery disease among subjects with and without diabetes and to assess the level of diabetes control among self-reported diabetic subjects.

The following are the different phases/component in theICMR INDIAB Study.

Phase I of the study which included Tamil Nadu,Chandigarh, Jharkhand and Maharashtra has been completed.

North East component of the study has also been completed in eightstudy including Assam, Arunachal Pradesh, Manipur, Meghalaya, Mizoram,Nagaland, Sikkim and Tripura.

Phase II of this study which includes 19 states/UT isongoing: The study has been completed nine states including Andhra Pradesh(undivided), Bihar, Punjab, Karnataka, Gujarat, Delhi , Madhya Pradesh, UttarPradesh and Rajasthan: ongoing in Kerala, Goa, Puducherry, Chhattisgarh andHaryana and the pending five states include West Bengal, Odisha, Uttarakhand,  Himachal Pradesh and Jammu and Kashmir

研究设计

研究类型
Observational

入排标准

年龄范围
20.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • •willing to give informed consent Individuals aged 20 years and above.

排除标准

  • •Not able to give informed consent.

结局指标

主要结局

Prevalence of Pre-diabetes,diabetes and associated complications

时间窗: 2008- 2020

次要结局

  • Prevalence rates of diabetes and prediabetes(2020)

研究者

申办方类型
Government funding agency

研究点 (30)

Loading locations...

相似试验